Researchers have carried out an in-depth analysis of 10,478 cancer genomes across 35 different cancer types, identifying 330 ...

For example, AI-powered tools are used to identify mutations in the BRCA1 and BRCA2 genes, which phenomenally raise the risk ...

In this Avera Medical Minute, one woman shares her story and the steps she’s taking to lower her risk for breast cancer.

Brisa Aschebrook-Kilfoy, Associate Professor of Family Medicine at UChicago, is an expert in conducting environmental exposure assessments. She is actively leading efforts to build resources to study ...

The firm is now inking revenue-generating contracts with other biotech companies for its drug response prediction and gene expression analysis capabilities.

Oncologists caution that at-home genetic tests taken up by millions of Americans looking to gauge their cancer risk are not ...

A molar pregnancy, also known as a hydatidiform mole, is an abnormal human pregnancy with no embryo and an overgrowth of the ...

Two patients exceed 14 months on treatment in Phase 2 trial of advanced ovarian cancerAllarity maintains a cash balance of $18.5 million, ...

Ask yourself how the genetic test results may affect your life. If the results come back positive, will you take steps to ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

For example, people of eastern European Jewish descent are known to be at a high risk for BRCA1 and BRCA2 gene mutations that increase the risk for breast and ovarian cancers. If you learn that ...

Evo is a large language model that is not trained on words but on the genomes of millions of microbes. It can accurately ...